[Effect of extract of Gingko biloba on soluble intercellular adhesion molecule-1 and soluble vascular cell adhesion molecule-1 in patients with early diabetic nephropathy].
Xu-sheng Li, Xiaoyan Fu, Xu-Jun Lang
May 1, 2007
Citations
6
Citations
Quality indicators
Journal
Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine
Semantic Scholar
Key Takeaway Key Takeaway: Gingko biloba extract can slow down the development of early diabetic nephropathy by decreasing serum levels of soluble intercellular adhesion molecule-1 and soluble vascular cell adhesion molecule-1.
Abstract
OBJECTIVE To investigate the effect of extract of Gingko biloba (EGb) on soluble intercellular cell adhesion molecule-1 (sICAM-1) and soluble vascular cell adhesion molecule-1 (sVCAM-1) in patients with early diabetic nephropathy (DN). METHODS Sixty-three patients with DN in early stage were randomly assigned to the control group (29 cases) and the treatment group (34 cases). Both groups were treated by routine treatment, and with EGb given to the treatment group additionally. The treatment course was 2 months. Serum sICAM-1 and sVCAM-1 were determined with ELISA before and after treatment, and urinary albumin excretion rate (UAER), fasting plasma glucose (FPG), serum creatinine (SCr) and blood lipids, etc. were examined as well. RESULTS The levels of serum sICAM-1 and sVCAM-1 were significantly lower in both groups after treatment than those before treatment (P < 0.05 or P < 0.01), and the decrement in the treatment group was more significant than that in the control group (P < 0.01). And the levels of UAER, SCr and blood lipids decreased in the treatment group after treatment (P < 0.05 or P < 0.01). CONCLUSION EGb could retard the development of early DN through decreasing the levels of serum sICAM-1 and sVCAM-1.